Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcus Biosciences (RCUS) Net Income: 2017-2024

Historic Net Income for Arcus Biosciences (RCUS) over the last 8 years, with Dec 2024 value amounting to -$283.0 million.

  • Arcus Biosciences' Net Income fell 46.74% to -$135.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$433.0 million, marking a year-over-year decrease of 60.37%. This contributed to the annual value of -$283.0 million for FY2024, which is 7.82% up from last year.
  • Per Arcus Biosciences' latest filing, its Net Income stood at -$283.0 million for FY2024, which was up 7.82% from -$307.0 million recorded in FY2023.
  • Over the past 5 years, Arcus Biosciences' Net Income peaked at $53.0 million during FY2021, and registered a low of -$307.0 million during FY2023.
  • Over the past 3 years, Arcus Biosciences' median Net Income value was -$283.0 million (recorded in 2024), while the average stood at -$285.7 million.
  • As far as peak fluctuations go, Arcus Biosciences' Net Income surged by 143.09% in 2021, and later slumped by 603.77% in 2022.
  • Over the past 5 years, Arcus Biosciences' Net Income (Yearly) stood at -$123.0 million in 2020, then skyrocketed by 143.09% to $53.0 million in 2021, then slumped by 603.77% to -$267.0 million in 2022, then fell by 14.98% to -$307.0 million in 2023, then increased by 7.82% to -$283.0 million in 2024.